Evaluation of the efficacy of a traditional product on fatty liver

Phase 3

Recruiting

• Conditions: on-alcoholic fatty liver.; Nonalcoholic steatohepatitis (NASH); K75.81

• Registration Number: IRCT20131214015790N3
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Confirmation of diagnosis of non-alcoholic fatty liver based on ultrasound (grades 1 to 3)
Age 18 to 70 years
Written and informed consent of the patient

Exclusion Criteria

Pregnancy or breastfeeding
Fatty liver secondary to alcohol consumption
Smoking
Taking hypoglycemic, hypolipidemic and anti-inflammatory drugs (any drug that affects liver function)
Other diseases such as viral hepatitis, coronary artery disease, kidney, lung and thyroid diseases

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fatty liver ultrasound grade. Timepoint: Beginning and end of the study (end of the second month). Method of measurement: Ultrasound in the same radiology center.;Serum AST level. Timepoint: Beginning and end of the study (end of the second month). Method of measurement: Beckman DU spectrophotometer.;Serum ALT level. Timepoint: Beginning and end of the study (end of the second month). Method of measurement: Beckman DU spectrophotometer.;Serum Alk-P level. Timepoint: Beginning and end of the study (end of the second month). Method of measurement: Beckman DU spectrophotometer.